SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

FDA approves Roche’s giredestrant combination for advanced breast cancer

The FDA approved Roche’s giredestrant combination for ESR1-mutated advanced breast cancer.

Related stories